926 related articles for article (PubMed ID: 20298966)
1. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
Tan CS; Koralnik IJ
Lancet Neurol; 2010 Apr; 9(4):425-37. PubMed ID: 20298966
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
Bauer J; Gold R; Adams O; Lassmann H
Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
[TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leukoencephalopathy.
Weissert R
J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression increases latent infection of brain by JC polyomavirus.
Bayliss J; Karasoulos T; Bowden S; Glogowski I; McLean CA
Pathology; 2011 Jun; 43(4):362-7. PubMed ID: 21532525
[TBL] [Abstract][Full Text] [Related]
5. Cortical and subcortical JC virus infection: two unusual cases of AIDS associated progressive multifocal leukoencephalopathy.
Sweeney BJ; Manji H; Miller RF; Harrison MJ; Gray F; Scaravilli F
J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):994-7. PubMed ID: 8057128
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy: clinical description and demonstration of the causal agent.
Carrada-Bravo T
Neurologia; 2005 Oct; 20(8):422-5. PubMed ID: 16220408
[TBL] [Abstract][Full Text] [Related]
7. The human JC polyomavirus (JCPyV): virological background and clinical implications.
Hirsch HH; Kardas P; Kranz D; Leboeuf C
APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
[TBL] [Abstract][Full Text] [Related]
8. JC virus granule cell neuronopathy in a child with CD40 ligand deficiency.
Hecht JH; Glenn OA; Wara DW; Wu YW
Pediatr Neurol; 2007 Mar; 36(3):186-9. PubMed ID: 17352955
[TBL] [Abstract][Full Text] [Related]
9. The risk of progressive multifocal leukoencephalopathy under biological agents used in the treatment of chronic inflammatory diseases.
Toussirot É; Bereau M
Inflamm Allergy Drug Targets; 2014; 13(2):121-7. PubMed ID: 24559124
[TBL] [Abstract][Full Text] [Related]
10. Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy.
Sabath BF; Major EO
J Infect Dis; 2002 Dec; 186 Suppl 2():S180-6. PubMed ID: 12424695
[TBL] [Abstract][Full Text] [Related]
11. JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
Travasarou M; Marousi S; Papageorgiou E; Karageorgiou CE
Clin Neurol Neurosurg; 2013 Jun; 115(6):827-9. PubMed ID: 22920632
[No Abstract] [Full Text] [Related]
12. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies.
Major EO
Annu Rev Med; 2010; 61():35-47. PubMed ID: 19719397
[TBL] [Abstract][Full Text] [Related]
13. The effect of plasma exchange on serum anti-JC virus antibodies.
Subramanyam M; Plavina T; Khatri BO; Fox RJ; Goelz SE
Mult Scler; 2013 Jun; 19(7):912-9. PubMed ID: 23232602
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?
Koralnik IJ
Ann Neurol; 2006 Aug; 60(2):162-73. PubMed ID: 16862584
[TBL] [Abstract][Full Text] [Related]
15. Polyoma nephropathy and progressive multifocal leukoencephalopathy in a renal transplant recipient.
Phillips T; Jacobs R; Ellis EN
J Child Neurol; 2004 Apr; 19(4):301-4. PubMed ID: 15163098
[TBL] [Abstract][Full Text] [Related]
16. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
18. JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.
Harypursat V; Zhou Y; Tang S; Chen Y
AIDS Res Ther; 2020 Jul; 17(1):37. PubMed ID: 32631361
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies and progressive multifocal leukoencephalopathy.
Berger JR; Houff SA; Major EO
MAbs; 2009; 1(6):583-9. PubMed ID: 20073129
[TBL] [Abstract][Full Text] [Related]
20. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
